Vaxart, Inc. to print 5000% impulsive wave ??

2024年12月20日

** The months ahead **

On the above 6 day chart price action has corrected over 96% since February 2021. A number of reasons now exist for a bullish outlook, they include:

1) Price action and RSI resistance breakouts.

2) Confirmation of support on past resistance.

3) Regular positive divergence. The divergence prints at a time price action breaks out after 4 years of active resistance.

4) The forecast is determined from a 2nd impulsive move as measured from the first.

Is it possible price action continues to correct? Sure.
Is it probable? No

Ww

Type: Trade
Risk: You decide
Timeframe for long: Remainder of the year.
Return: 4000-5000%
Stop loss: Will say elsewhere

1月3日

交易开始

Past resistance confirms support.

1月14日

注释

Post market close:

Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial
Jan 14, 202501:55 GMT+1


Independent Data Safety Monitoring Board (DSMB) recommends study to proceed without modifications based on initial safety assessment of 400 participant 30-day data

The company plans to progress the trial to enrolment of 10,000 participants, upon favorable review from the U.S. Food and Drug Administration (FDA) and upon Biomedical Advanced Research and Development Authority (BARDA) approval.